DMT310
DMT310-009
Phase 3 small_molecule completed
Quick answer
DMT310 for Acne Vulgaris is a Phase 3 program (small_molecule) at Dermata Therapeutics with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Dermata Therapeutics
- Indication
- Acne Vulgaris
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed